Skip to main content
logo
NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
7.20
+0.01 (0.14%)
At close: Mar 30, 2026, 4:00 PM EDT
7.29
+0.09 (1.25%)
Pre-market: Mar 31, 2026, 7:01 AM EDT

NeoGenomics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
727.33660.57591.64509.73484.33
Revenue Growth (YoY)
10.11%11.65%16.07%5.24%8.97%
Cost of Revenue
413.04370.47347.04321.83297.27
Gross Profit
314.29290.1244.6187.9187.06
Selling, General & Admin
365.34344.39313.94310.68283.94
Research & Development
37.0831.1627.3130.3321.87
Other Operating Expenses
27.756.6611.094.52-
Total Operating Expenses
430.17382.21352.34345.52305.81
Operating Income
-115.88-92.11-107.74-157.62-118.75
Interest Income
-9.07-18.43-16.9-6.088.22
Interest Expense
-3.75-6.62-6.91-7.583.14
Other Non-Operating Income (Expense)
-0.30.38-0.640.21-108.76
Total Non-Operating Income (Expense)
-13.12-24.67-24.45-13.44-97.4
Pretax Income
-110.27-80.68-97.1-159.34-15.08
Provision for Income Taxes
-2.24-1.95-9.13-15.09-6.73
Net Income
-108.03-78.73-87.97-144.25-8.35
Net Income to Common
-108.03-78.73-87.97-144.25-8.35
Shares Outstanding (Basic)
128127126124120
Shares Outstanding (Diluted)
128127126124120
Shares Change (YoY)
1.14%0.92%1.03%3.55%7.31%
EPS (Basic)
-0.84-0.62-0.70-1.16-0.07
EPS (Diluted)
-0.84-0.62-0.70-1.16-0.07
Free Cash Flow
-21.78-34.04-30.71-96.88-90.87
Free Cash Flow Per Share
-0.17-0.27-0.24-0.78-0.76
Gross Margin
43.21%43.92%41.34%36.86%38.62%
Operating Margin
-15.93%-13.94%-18.21%-30.92%-24.52%
Profit Margin
-14.85%-11.92%-14.87%-28.30%-1.72%
FCF Margin
-2.99%-5.15%-5.19%-19.01%-18.76%
EBITDA
-48.06-19.56-35.15-88.19-65.4
EBITDA Margin
-6.61%-2.96%-5.94%-17.30%-13.50%
EBIT
-115.88-92.11-107.74-157.62-118.75
EBIT Margin
-15.93%-13.94%-18.21%-30.92%-24.52%
Effective Tax Rate
2.03%2.42%9.40%9.47%44.63%
Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q